Stephen J. Ubl

Stephen J. Ubl

business executive United States

Stephen J. Ubl is the president and CEO of PhRMA, the leading trade organization representing the pharmaceutical industry in the United States, known for advocating on behalf of drug manufacturers regarding policies that affect their business and the development of new medications.

Global Media Ratings
Dominance
0.01%
Persistence
0 wks
Reach
245,222
Power
7,733$
Sentiment
4.00
Countries Mentioned
Country Mentions Sentiment Dominance + Persistence x Population = Reach x GDP (millions) = Power
United States 1 4.00 0.02% +0% 331,002,651 74,718 $21,000,000 4,740$
Canada 1 4.00 0.06% +0% 38,005,238 21,044 $1,700,000 941$
Mexico 1 4.00 0.09% +0% 128,932,753 120,273 $1,200,000 1,119$
Dominican Republic 1 4.00 0.06% +0% 10,847,910 6,918 $89,000 57$
United Kingdom 1 4.00 0.03% +0% 67,886,011 21,927 $2,700,000 872$
Montenegro 1 3.00 0.05% +0% 628,066 342 $5,500 3$
Totals 6 577,302,629 245,222 $26,694,500 7,732$
Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

United Kingdom United Kingdom: Stephen J Ubl, president of the Pharmaceutical Research and Manufacturers of America, criticized the executive order. 4

BBC: What's in it, and will it work?

Canada Canada: Stephen J. Ubl, the president and CEO of PhRMA, said in a statement that importing foreign prices will cut billions of dollars from Medicare. 4

The Globe and Mail: Trump says he’ll set 30-day deadline for drugmakers to lower the cost of prescription drugs